Clinical significance of productive immunoglobulin heavy chain gene rearrangements in childhood acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 52, Issue 9, 2011, Pages 1751-1757

  Katsibardi, Katerina ^a   Braoudaki, Maria ^a   Papathanasiou, Chrissa ^a   Karamolegou, Kalliopi ^a   Tzortzatou Stathopoulou, Fotini ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

acute lymphoblastic leukemia; CDR3 region; childhood; Heavy chain immunoglobulin rearrangement; IMGT; productivity

Indexed keywords

IGHD2; IGHD3; IGHJ4; IGHJ6; IGHV3; IGHV6; IMMUNOGLOBULIN HEAVY CHAIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RECURRENCE; CANCER RISK; CHILD; FEMALE; GENE REARRANGEMENT; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOGLOBULIN VARIABLE REGION; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; SURVIVAL RATE;

CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; INFANT; KAPLAN-MEIER ESTIMATE; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS;

EID: 80052061603     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.582907     Document Type: Article

References (37)

1. Alt FW, Yancopoulos GD, Blackwell TK, et al. Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J 1984;3:1209-1219.
2. Matsuda F, Ishii K, Bourvagnet P, et al. The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J Exp Med 1998;188:2151-2162. (Pubitemid 28562531)
3. Mortuza FY, Moreira IM, Papaioannou M, et al. Immuno-globulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of J(H)-proximal variable gene segments. Blood 2001;97:2716-2726.
4. Corbett SJ, Tomlinson IM, Sonnhammer EL, Buck D, Winter G. Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, 'minor' D segments or D-D recombination. J Mol Biol 1997;270:587-597. (Pubitemid 27313798)
5. Mattila PS, Schugk J, Wu H, Mäkelä O. Extensive allelic sequence variation in the J region of the human immunoglo-bulin heavy chain gene locus. Eur J Immunol 1995;25:2578-2582.
6. Kiyoi H, Naoe T, Horibe K, Ohno R. Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells. J Clin Invest 1992;89:739-746.
7. Wasserman R, Ito Y, Galili N, et al. The pattern of joining (JH) gene usage in the human IGH@ chain is established predominantly at the B precursor cell stage. J Immunol 1992;149:511-516.
8. Raaphorst FM, Raman CS, Tami J, Fischbach M, Sanz I. Human Ig heavy chain CDR3 regions in adult bone marrow pre-B cells display an adult phenotype of diversity: evidence for structural selection of DH amino acid sequences. Int Immunol 1997;9:1503-1515. (Pubitemid 27434682)
9. Rao SP, Riggs JM, Friedman DF, Scully MS, LeBien TW, Silberstein LE. Biased VH gene usage in early lineage human B cells: evidence for preferential Ig gene rearrangement in the absence of selection. J Immunol 1999;163:2732-2740. (Pubitemid 29399199)
10. Kraj P, Rao SP, Glas AM, Hardy RR, Milner EC, Silberstein LE. The human heavy chain Ig V region gene repertoire is biased at all stages of B cell ontogeny, including early pre-B cells. J Immunol 1997;158:5824-5832. (Pubitemid 127483989)
11. Marshall AJ, Paige CJ, Wu GE. V(H) repertoire maturation during B cell development in vitro: differential selection of Ig heavy chains by fetal and adult B cell progenitors. J Immunol 1997;158:4282-4291. (Pubitemid 127483929)
12. Bennett JM, Catovsky D, Daniel MT, et al. The morphological classification of acute lymphoblastic leukemia: concordance among observers and clinical correlations. Br J Haematol 1981;47:553-561. (Pubitemid 11051356)
13. Tzortzatou-Stathopoulou F, Moschovi MA, Papadopoulou AL, et al. Could intensified treatment in childhood acute lymphoblastic leukemia improve outcome independently of risk factors? Eur J Haematol 2005;75:361-369. (Pubitemid 41445074)
14. Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lym-phoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007;370:240-250. (Pubitemid 47082422)
15. Pongers-Willemse MJ, Seriu T, Stolz F, et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobu-lin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia 1999;13:110-118. (Pubitemid 29043725)
16. Katsibardi K, Moschovi MA, Braoudaki M, Papadhimitriou SI, Papathanasiou C, Tzortzatou-Stathopoulou F. Sequential monitoring of minimal residual disease in acute lymphoblastic leukemia: 7-year experience in a Pediatric Hematology-Oncology unit. Leuk Lymphoma 2010;51:846-852.
17. Lefranc MP, Giudicelli V, Ginestoux C, et al. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 1999;27:209-212. (Pubitemid 29209441)
18. Giudicelli V, Duroux P, Ginestoux C, et al. IMGT/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic Acids Res 2006;34(Database issue): D781-D784.
19. Souto-Carneiro MM, Longo NS, Russ DE, Sun HW, Lipsky PE. Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER. J Immunol 2004;172:6790-6792.
20. Lefranc MP. Nomenclature of the human immunoglobulin heavy (IGHat) genes. Exp Clin Immunogenet 2001;18:100-116.
21. Riffenburgh R. Statistics in medicine. 2nd ed. Burlington, MA: Elsevier Academic Press; 2006.
22. Li A, Rue M, Zhou J, et al.; Dana-Farber Cancer Institute ALL Consortium. Utilization of Ig heavy chain variable, diversity, and joining gene segments in children with B-lineage acute lymphoblastic leukemia: implications for the mechanisms of VDJ recombination and for pathogenesis. Blood 2004;103:4602-4609. (Pubitemid 38745989)
23. Malynn BA, Yancopoulos GD, Barth JE, Bona CA, Alt FW. Biased expression of JH-proximal VH genes occurs in the newly generated repertoire of neonatal and adult mice. J Exp Med 1990;171:843-859. (Pubitemid 20088986)
24. Van Es JH, Raaphorst FM, van Tol MJ, Meyling FH, Logtenberg T. Expression pattern of the most JH-proximal human VH gene segment (VH6) in the B cell and antibody repertoire suggests a role of VH6-encoded IgM antibodies in early ontogeny. J Immunol 1993;150:161-168. (Pubitemid 23069791)
25. Yu CC, Larijani M, Miljanic IN, Wu GE. Differential usage of VH gene segments is mediated by cis elements. J Immunol 1998;161:3444-3454.
26. Pascual V, Verkruyse L, Casey ML, Capra JD. Analysis of Ig H chain gene segment utilization in human fetal liver. Revisiting the 'proximal utilization hypothesis'. J Immunol 1993;151:4164-4172. (Pubitemid 23298749)
27. Cole-Sinclair M, Foroni L, Wright F, Mehta A, Prentice HG, Hoffbrand AV. Minimal residual disease in acute lympho-blastic leukemia-PCR analysis of immunoglobulin gene rearrangements. Leuk Lymphoma 1993;11:49-58. (Pubitemid 24024976)
28. Steenbergen EJ, Verhagen OJ, van Leeuwen EF, et al. B precursor acute lymphoblastic leukemia third complementarity-determining regions predominantly represent an unbiased recombination repertoire: leukemic transformation frequently occurs in fetal life. Eur J Immunol 1994;24:900-908. (Pubitemid 24093786)
29. Souto-Carneiro MM, Sims GP, Girschik H, Lee J, Lipsky PE. Developmental changes in the human heavy chain CDR3. J Immunol 2005;175:7425-7436. (Pubitemid 41713440)
30. Tuaillon N, Capra JD. Evidence that terminal deoxynucleo-tidyltransferase expression plays a role in Ig heavy chain gene segment utilization. J Immunol 2000;164:6387-6397. (Pubitemid 30408821)
31. Lo Nigro L, Cazzaniga G, Di Cataldo A, et al. Clonal stability in children with acute lymphoblastic leukemia (ALL) who relapsed five or more years after diagnosis. Leukemia 1999;13:190-195. (Pubitemid 29092651)
32. Li A, Zhou J, Zuckerman D, et al. Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection. Blood 2003;102:4520-4526. (Pubitemid 37494119)
33. Foroni L, Hoffbrand AV. Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 2002;15:71-90.
34. Meleshko AN, Lipay NV, Stasevich IV, Potapnev MP. Rearrangements of IGHat, TCRD and TCRG genes as clonality marker of childhood acute lymphoblastic leukemia. Exp Oncol 2005;27:319-324. (Pubitemid 43139365)
35. Szczepański T, Willemse MJ, van Wering ER, van Weerden JF, Kamps WA, van Dongen JJ. Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogen-otype with a highfrequency of oligoclonality and hyperdiploidy of chromosome 14. Leukemia 2001;15:1415-1423. (Pubitemid 32785311)
36. Moreira I, Papaioannou M, Mortuza FY, et al. Heterogeneity of VH-JH gene rearrangement patterns: an insight into the biology of B cell precursor ALL. Leukemia 2001;15:1527-1536. (Pubitemid 32994671)
37. Csinady E, van der Velden VH, Joas R, et al. Chromosome 14 copy number-dependent IGH gene rearrangement patterns in high hyperdiploid childhood B-cell precursor ALL: implications for leukemia biology and minimal residual disease analysis. Leukemia 2009;23:870-876.